"First Amendment--what is that? The FDA believes the Bill of Rights starts with number two," quipped David G. Adams, attorney with the Venable Firm in Washington, D.C. Formerly with the Food and Drug Administration, Adams has switched camps and is now in private practice representing biomedical companies. On that note, Adams began his analysis of the recent court ruling curtailing the FDA's power to regulate pharmaceutical and medical device companies. He addressed the first plenary ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Court's FDA Ruling Puts the Squeeze on CME, you'll also gain access to exclusive premium content.

Already registered? here.